Proprietary chromatographic techniques (e.g., immobilized metal affinity chromatography for His-tagged versions) .
Parameter | Specification |
---|---|
Purity | >90% (SDS-PAGE, RP-HPLC) |
Endotoxin Levels | <1.0 EU/μg |
Activity | ED₅₀ <5.0 μg/mL in cell adhesion assays |
SCGB1A1 Human, His exhibits key bioactivities mirroring the native protein:
Anti-Inflammatory Effects:
Anti-Tumorigenic Activity:
Immunomodulation:
Cell Culture: Used to study macrophage polarization (e.g., blunting LPS-induced cytokine storms) .
Drug Discovery: Screens for compounds targeting SCGB1A1-related pathways in asthma or cancer .
Knockout Mice: Scgb1a1⁻/⁻ mice exhibit exacerbated lung inflammation and fibrosis, validating therapeutic potential .
Asthma and COPD: Reduced SCGB1A1 levels in patient sera predict airway hyperresponsiveness and disease progression .
Cancer: High SCGB1A1 expression in HNSCC tumors correlates with prolonged survival and chemoresistance .
Infection Models: Exogenous SCGB1A1 suppresses viral/bacterial-induced cytokine surges (e.g., IL-8, MCP-1) .
Uteroglobin is a multifunctional protein with several biological properties:
The protein plays several crucial roles in the body:
Recombinant human uteroglobin with a His tag is a laboratory-produced version of the protein. It is typically expressed in HEK 293 cells and purified to a high degree of purity (>97%) with low endotoxin levels (<1 EU/µg) . The His tag facilitates purification and detection of the protein in various experimental applications.